Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.
2.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
3.

Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.

Hanania NA, Boota A, Kerwin E, Tomlinson L, Denis-Mize K.

Drugs. 2009 Jun 18;69(9):1205-16. doi: 10.2165/00003495-200969090-00005.

PMID:
19537837
4.

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.

Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ Jr, Kesten S, Towse L.

Chest. 2002 Jul;122(1):47-55.

PMID:
12114338
5.

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

Ambrosino N, Foglio K, Balzano G, Paggiaro PL, Lessi P, Kesten S; Tiotropium Multicentric Italian Study Group..

Int J Chron Obstruct Pulmon Dis. 2008;3(4):771-80.

6.

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S.

Chest. 2005 Mar;127(3):809-17.

PMID:
15764761
7.

Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.

Tashkin DP, Hanania NA, McGinty J, Denis-Mize K, Chaudry I.

Adv Ther. 2009 Nov;26(11):1024-34. doi: 10.1007/s12325-009-0080-z. Epub 2009 Dec 2.

PMID:
19953349
8.

Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.

Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K.

Respir Med. 2008 Apr;102(4):479-87. doi: 10.1016/j.rmed.2007.12.019. Epub 2008 Feb 6.

9.

The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.

Casaburi R, Briggs DD Jr, Donohue JF, Serby CW, Menjoge SS, Witek TJ Jr.

Chest. 2000 Nov;118(5):1294-302.

PMID:
11083677
10.

Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.

Hodder R, Kesten S, Menjoge S, Viel K.

Int J Chron Obstruct Pulmon Dis. 2007;2(2):157-67.

11.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators..

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

12.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators..

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

13.
14.

Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.

van Noord JA, Aumann JL, Janssens E, Verhaert J, Smeets JJ, Mueller A, Cornelissen PJ.

Chest. 2006 Mar;129(3):509-17.

PMID:
16537846
15.

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.

Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S.

Thorax. 2003 May;58(5):399-404. Erratum in: Thorax. 2005 Feb;60(2):105.

17.

Tiotropium versus placebo for chronic obstructive pulmonary disease.

Karner C, Chong J, Poole P.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009285. doi: 10.1002/14651858.CD009285.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(7):CD009285.

PMID:
22786525
18.

[The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].

Ma J, Zhou Z, Tang Y, Zhong N.

Zhonghua Nei Ke Za Zhi. 2014 Dec;53(12):964-8. Chinese.

PMID:
25623564
19.

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L, Cornelissen PJ; Dutch/Belgian Tiotropium Study Group..

Eur Respir J. 2002 Feb;19(2):209-16.

20.

Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD.

Fuhr R, Magnussen H, Sarem K, Llovera AR, Kirsten AM, Falqués M, Caracta CF, Garcia Gil E.

Chest. 2012 Mar;141(3):745-52. doi: 10.1378/chest.11-0406. Epub 2011 Sep 8.

PMID:
21903737

Supplemental Content

Support Center